Capivasertib China PK Study

Clinical trial NCT04742036 · COMPLETED

Trial details

NCT number: NCT04742036
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumours

Start date: 2021-02-22
Primary completion: 2022-07-29
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.